Dexcom G7 unlocks diabetes management on the Apple Watch
Time’s almost up! There’s only one week left to request an invite to The AI Impact Tour on June 5th. Don’t miss out on this incredible opportunity to explore various methods for auditing AI models. Find out how you can attend here.
Diabetes management is going as the hands-free as the Dexcom G7 glucose monitor can now connect directly to Apple Watch in the U.S.
That gives people the confidence to know their blood sugar levels — something critical for diabetes patients — even when their iPhone isn’t with them. In the past, diabetes patients had to meticulously manage their glucose levels. Too low and they could pass out. Too high and it could be worse. But now it’s easier to manage given the advance of glucose monitoring technology.
The Dexcom G7 Continuous Glucose Monitoring (CGM) System now connects directly to Apple Watch in the United States. Dexcom G7 is the first and only CGM available with Direct to Apple Watch, offering users the freedom and convenience of real-time glucose readings on their wrist even when their iPhone isn’t with them.
“At Dexcom, our users are at the heart of everything we do. Direct to Apple Watch has been one of our most requested features and we’re thrilled to roll it out to Dexcom G7 users in the U.S. and around the world,” said Jake Leach, executive vice president and chief operating officer at Dexcom, in a statement. “We’ve long believed that people with diabetes should be able to view their CGM data where and how they choose. Direct to Apple Watch is a testament to that, allowing people with diabetes flexibility and choice in how they manage their health.”
June 5th: The AI Audit in NYC
Join us next week in NYC to engage with top executive leaders, delving into strategies for auditing AI models to ensure optimal performance and accuracy across your organization. Secure your attendance for this exclusive invite-only event.
Using its own dedicated Bluetooth connection, Dexcom G7 sends glucose information and personalized alerts right to a user’s Apple Watch, allowing them to go for a run, enjoy a dinner out, and feel confident leaving their iPhone behind. Dexcom G7 is the only CGM system that can display glucose on multiple devices simultaneously and independently, including on a smartphone, smart watch, receiver or connected automated insulin delivery system, the company said.
In addition to the benefits of using Direct to Apple Watch with Dexcom G7, people with diabetes can track other key health metrics that can impact glucose levels using Apple’s Activity, Cycle Tracking, Sleep, and other health features on Apple Watch, iPhone and iPad. All of this data is stored securely in the Health app, where it can be viewed alongside Dexcom G7 data users choose to store in the Health app so all of their diabetes health information is accessible in one place. Apple products are built with strong privacy protections and users have control over their data in the Health app.
“Having used Direct to Apple Watch with Dexcom G7 for the last few months, being able to glance at my wrist and see my glucose levels in real-time has been a game changer,” said Dexcom Warrior Beth McDaniel of Northern Ireland, in a statement. “For the first time since being diagnosed, I can leave my phone at home without worrying and enjoy my daily activities with the confidence that I have the information I need to help keep my diabetes under control.”
Direct to Apple Watch is now available to Dexcom G7 users in the United States, United Kingdom and Ireland, with additional markets launching later this month. To use Direct to Apple Watch, users must have the Dexcom G7 app version 2.1, Apple Watch Series 6 or later running watchOS 10 or later, and an iPhone running iOS 17 or later.
